Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

BIOLOGICAL(4)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11
Phase 24

Trial Status

Completed4

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT02704364Phase 2Completed
A Study of NGM282 in Patients With Primary Sclerosing Cholangitis
Primary Sclerosing Cholangitis
StudydirectorStart date: 2016-03-01
NCT02026401Phase 2Completed
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Primary Biliary Cirrhosis
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

NGM Biopharmaceuticals, Inc

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02704364Phase 2StudyDirector

A Study of NGM282 in Patients With Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis
Completed
NCT02026401Phase 2StudyDirector

Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis
Completed
NCT02135536Phase 2StudyDirector

Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis
Completed
NCT02649062Phase 1/2StudyDirector

Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals

Functional Constipation
Completed

All 4 trials loaded